Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues

Valentina Bracun, Joseph Pierre Aboumsallem, Peter van der Meer, Rudolf A. de Boer*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

19 Citations (Scopus)

Abstract

Purpose of the Review: As the number of cancer survivors increases due to early screening and modern (antineoplastic) treatments, cancer treatment associated cardiotoxicity (CTAC) is becoming an increasing health burden that affects survival and quality of life among cancer survivors. Thus, clinicians need to identify adverse events early, in an effort to take suitable measures before the occurrence of permanent or irreversible cardiac dysfunction. Recent Findings: Cardiac troponin (cTn) and B-type natriuretic peptide (BNP) have been proven to detect subclinical cardiotoxicity during antineoplastic treatment. As such, these cardio-specific biomarkers could predict which patients are at risk of developing CTAC even before the start of therapy. Nevertheless, there are inconsistent data from published studies, and the recommendations regarding the use of these biomarkers and their validity are mostly based on expert consensus opinion. Summary: In this review, we summarize available literature that evaluates biomarkers of CTAC, and we encourage strategies that integrate circulating biomarkers and cardiac imaging in identifying cancer patients that are at high risk.

Original languageEnglish
Article number67
JournalCurrent Oncology Reports
Volume22
Issue number7
DOIs
Publication statusPublished - 1 Jul 2020
Externally publishedYes

Bibliographical note

Funding Information:
This work is supported by the European Research Council (ERC CoG 818715, SECRETE-HF).

Publisher Copyright:
© 2020, The Author(s).

Fingerprint

Dive into the research topics of 'Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues'. Together they form a unique fingerprint.

Cite this